Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

We know that the company's Ifenprodil focus had modified and that the company"s efforts were mainly COVID in 2020-2021. They got it done under adverse issues. A Phase 3 was not pursued due to costs and vaccinations. The company PR'ed the strong ILK-6 data and obviously has that Trial's data as support for future applications.

IPF/CC was delayed due to COVID but many here hope that Data may finally substantiate Ifenprodil's value for these Lung diseases and to support other Trial applications.

2021 brought licensing of Sub-hallucinogenic micro dose DMT research to pursue along with world class advisors. UK-MHRA applications in 2-2022.

AGN also found and licensed the Stroke research from Dr North (Topotecan) about the SCLC/Pancreatic tumor stuff. Very encouraging, IMO. (personal interest in cancer)

Not bad for a speculative investment, IMO. Buy -Hold - Sell...

I hope you're right about the FDA and implied UK-MHRA approvals of Clinical Trials. I've seen one with DMT and smoking.?.
BUTT... Of course it's not that easy. JMHFO...GLTA...